Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Myasthenia Gravis × Oxaloacetic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 4 fludarabine 3 thymoglobulin 1 Pyridostigmine Bromide 1 Oxaloacetic Acid 1 Methylprednisolone 1 Mesna 1 Hizentra 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04965987 2025-07-11

Oxaloacetate in Myasthenia Gravis

University of Kansas Medical Center

Phase 1 Withdrawn

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡